2023 Aug 23
A New Targeted Treatment Shows Promise for Select Patients with Stomach Cancer
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy... Read more